Industry News
AtCor forecasts profit in 2013
Medical device manufacturer AtCor (ASX:ACG) expects to report a profit in this financial year following strong sales of its SphygmoCor diagnostic device. [ + ]
Victorian Infection and Immunity Network gets $300K injection from Vic government
A collaborative network of researchers in infection and immunity has received a $300,000 grant from the Victorian government to encourage industry partnerships. [ + ]
Biotechs up after All Ordinaries surge
Life science stocks have enjoyed a boost alongside the broader share market, with stocks such as CSL (ASX:CSL) hitting historic highs. [ + ]
Immune cell death defects linked to autoimmune diseases
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body’s own tissues. [ + ]
Discovery shows genetic causes of rare bone condition
Researchers at the University of Oxford have discovered two new genetic causes of craniosynostosis, a rare bone condition that can inhibit brain growth in children. [ + ]
ResMed revenues up thanks to strong sales
ResMed (ASX:RMD) has seen revenues increase by 13% for the December quarter year on year with a dividend coming in February. [ + ]
World’s smallest spanner puts a new twist on microscopic manipulation
By harnessing laser light’s ability to gently push and pull microscopic particles, researchers have created the fibre-optic equivalent of the world’s smallest spanner. [ + ]
Researchers identify enzyme involved in deadly brain tumours
In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and the malignant tumour glioblastoma multiforme. [ + ]
Cellmid antibodies reduced kidney damage in mice
Cellmid’s (ASX:CDY) anti-midkine antibodies were able to reduce kidney damage and preserve function in an animal model of diabetic nephropathy. [ + ]
Uscom protocol slashed sepsis deaths: study
A Bathurst hospital reduced sepsis-related deaths by 94% by adopting a treatment protocol involving the use of Uscom (ASX:UCM) diagnostics tech, according to a new study. [ + ]
Allied Healthcare closes $4.6m capital raising
Allied Healthcare (ASX:AHZ) will put the $4.6m raised in a placement and SPP towards launching its CardioCel heart patch as well as phase I trials of its DNA vaccine against herpes. [ + ]
Abraxane extends life in advanced pancreatic cancer patients
A phase III trial has shown Celgene’s Abraxane, distributed here by Specialised Therapeutics, has a significant impact on survival in patients with advanced pancreatic cancer. [ + ]
Men more likely than women to commit scientific fraud
Male scientists are far more likely to commit fraud than females and the fraud occurs across the career spectrum, from trainees to senior faculty. [ + ]
Universal Biosensors expecting to launch new diagnostic in 2013
Universal Biosensors (ASX:UBI), in partnership with Siemens, expects to see its blood coagulation product hit the shelves this year, further boosting revenues for the company. [ + ]
Genetics discovery leads to migraine treatment
The discovery of a genetic mutation several years ago has led to a new treatment using vitamin B and folic acid that is proving successful in treating migraines. [ + ]
